Nick Higgins

Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom.

Exel Plc used to provide logistics services, including strategic management of the flow and storage of materials. It divided its logistics operations into two complementary segments, which included ground-based supply chain management services such as warehousing and distribution, assembly and just-in-time services. It also used to provide customer focused solutions to manufacturing and retail industries. The company was headquartered in Bracknell, UK

McKechnie Plc designs, develops, and manufactures specialist engineering components, engineered plastics, and consumer products. The company is headquartered in Alcester, the United Kingdom.

The Heart Hospital Ltd. provides specialised cardiac healthcare services. The company is based in London, UK and ultimately controlled by the Government of United Kingdom. The Heart Hospital was acquired by National Health Service from Parkway Holdings Ltd. on August 08, 2001 for $38.97 million.

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.

Part of Ambu A/S, King Systems Corp. is a company that manufactures disposable airway management devices. The company is based in Noblesville, IN. Steve Davis has been the CEO of the company since 2011. King Systems was acquired by Ambu A/S from Consort Medical Ltd. on February 15, 2013 for $170 million.

Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom.

Part of Recipharm AB, Bespak Europe Ltd. designs and manufactures medical devices. The company is based in Norfolk, UK. The British company was founded in 1959. The CEO is Keyvan Djamarani.

Part of Lendlock Group Ltd., Integrated Aluminium Components Ltd. is a British company that manufactures and sells anodized parts and deep drawn pressing products. The company is based in Guilden Sutton, UK. The company was founded in 2007. Integrated Aluminium Components was acquired by Specialist Anodising Co. Ltd. from Recipharm AB on December 21, 2023.

Lovell Powerminster Ltd. engages in providing facilities management services that include both planned and reactive maintenance to housing associations and housing PFI schemes. The company is headquartered in London, the United Kingdom.

The Parkinson's Disease Society of the United Kingdom is a non-profit organization that aims to support research on Parkinson's disease. The non-profit company is based in London, UK. The British company provides health information about Parkinson's for patients, caregivers, and family members. The organization also supports researchers to involve patients and the public in their work. The company offers a Parkinson's Learning Pathway for occupational therapists, physiotherapists, and speech and language therapists. The company was founded in 1969 by Mali Jenkins. Caroline Rassell has been the CEO of the company since 2021.

Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom.

STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain.

Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Picker Institute Europe provides health and social care services. The non-profit company is based in Oxford, UK. The British company was founded in 2000. Chris Graham has been the CEO of the company since 2011.

NHS England provides primary and mental health care services and is ultimately controlled by the Government of United Kingdom. The company is based in Redditch, UK. The CEO of the British company is Amanda Pritchard.

Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.

Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany.

Part of Recipharm AB, Medical House Products Ltd. is a British company that manufactures medical and surgical equipment. The company is based in Hemel Hempstead, UK.

Birmingham Women's NHS Foundation Trust provides health care services. The non-profit company is based in Edgbaston, UK.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

Centre for Engineering & Manufacturing Excellence Ltd. was founded in 2001. The non-profit company is based in Rainham, UK. The British company provides research, business support, skills, and education campus services.

Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom.

Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany.

LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.

Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC.

Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert.

SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation.

UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom.

T3 Pharmaceuticals AG provides medicines and treatment for cancer patient. The company was founded in May 2015 by Simon J. Ittig, Christoph A. Kasper, Marlise Amstutz and Helmut H. Kessmann and is headquartered in Basel, Switzerland.

Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium.